CD4 and hepatocellular carcinoma: Our meticulous analysis reveals that, relative to the healthy control cohort, HCC patients manifest decreased expression of KLRB1 on CD3+ T cells (total T cells) in their peripheral blood, as well as attenuated expression on CD4+ and CD8+ T cells.